Recombinant Human PCSK9 Protein (AVI Tag)(Active)
SKU: PKSH032946-100
Recombinant Human PCSK9 Protein (AVI Tag)(Active)
SKU # | PKSH032946 |
Expression Host | HEK293 Cells |
Description
Synonyms | NARC-1, NARC1, Neural Apoptosis-Regulated Convertase 1, PC9, PCSK9, Proprotein Convertase 9, Proprotein Convertase Subtilisin/Kexin Type 9, Subtilisin/Kexin-Like Protease PC9 |
Species | Human |
Expression Host | HEK293 Cells |
Sequence | Gln31-Gln692(Val474Ile,Gly670Glu) |
Accession | Q8NBP7 |
Calculated Molecular Weight | 14&59 kDa |
Observed Molecular Weight | 19&65 kDa |
Tag | C-Avi |
Bio-activity | Immobilized Human LDLR-His(Cat: PKSH033435) at 10μg/ml(100 μl/well) can bind Human PCSK9-BiotinylatedAVI. The ED50 of Human PCSK9-BiotinylatedAVI is 126.41ug/ml. |
Properties
Purity | > 95 % as determined by reducing SDS-PAGE. |
Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
Shipping | This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C. |
Formulation | Supplied as a 0.2 μm filtered solution of 50mM HEPES, 150mM NaCl, 20% Glycerol, pH 7.4. |
Reconstitution | Not Applicable |
Background
Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER ; the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2); and play a role in the neural development.